From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird
-
ナレーター：
-
著者：
このコンテンツについて
New Podcast Episode! 🎙️
For the second episode of this brand-new season, we had the pleasure of hosting Caroline Arrighi-Savoie, Senior Associate - Healthcare & Life Sciences at Bird & Bird France and one of Bird & Bird’s clients, Edouard Gasser, CEO and co-founder of Tilak Healthcare.
They will discuss:
- How Tilak's innovative product, Odysight, changes the game by combining remote monitoring of visual parameters with a fun patient experience powered by video games
- How to overcome business and regulatory challenges (securing funding, clinical validation, regulatory pathway, market access, etc.) to reach commercial maturity for an innovative healthcare company as Tilak
- How partnering with Bird & Bird lawyers on legal but also business aspects helped Tilak meet these challenges and build their competitive edge in the market
- How different innovative healthcare products regulatory regimes may impact your go-to-market strategy
- Practical advice for entrepreneurs in an highly regulated healthtech sector
🔊 Listen now!
Let us know your thoughts in the comments!
Hosted by Ausha. See ausha.co/privacy-policy for more information.